Grant: Operating Grant
McGill University
$377,699.00
Tumour suppressor mediated mechanisms of angiogenesis inhibition
EF 2010-11
Résumé
In order for tumours to become large and life threatening they must first develop a network of blood vessels in order to deliver oxygen and nutrients to cancer cells. The process of blood vessel formation, called angiogenesis, is an absolutely necessary step in the formation of solid tumours and an ideal point at which novel therapeutic agents can be developed. Our previous work demonstrated that the natural mechanisms of the human body that prevent cancer do so by inhibiting angiogenesis. We showed that the p53 tumour suppressor, which is mutated in half of all human cancers, stimulates the production of a natural anti-angiogenic factor called Arresten. When p53 becomes mutated in tumours, levels of Arresten are decreased and cancer growth accelerates. In this current application we propose to study the levels of Arresten circulating in the bloodstream of patients with ovarian, breast and prostate cancer. It is our hope that the development of this form of test can provide a new and powerful tool for the diagnosis of these cancers and possibly indicate when events such as metastasis have occurred. In addition, we will study the biochemical pathways in human cells by which Arresten is produced in the hopes of learning how production of such factors can be enhanced in the fight against cancer.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
224817
Name
Teodoro Jose G
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Progression & Therapeutics 2
Projecttitle
Tumour suppressor mediated mechanisms of angiogenesis inhibition
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$377,699
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Angiogenesis; Angiogenesis Inhibitors; Cancer Biology; Cancer Therapeutics; P53; Tumour Suppressors
Abstract
In order for tumours to become large and life threatening they must first develop a network of blood vessels in order to deliver oxygen and nutrients to cancer cells. The process of blood vessel formation, called angiogenesis, is an absolutely necessary step in the formation of solid tumours and an ideal point at which novel therapeutic agents can be developed. Our previous work demonstrated that the natural mechanisms of the human body that prevent cancer do so by inhibiting angiogenesis. We showed that the p53 tumour suppressor, which is mutated in half of all human cancers, stimulates the production of a natural anti-angiogenic factor called Arresten. When p53 becomes mutated in tumours, levels of Arresten are decreased and cancer growth accelerates. In this current application we propose to study the levels of Arresten circulating in the bloodstream of patients with ovarian, breast and prostate cancer. It is our hope that the development of this form of test can provide a new and powerful tool for the diagnosis of these cancers and possibly indicate when events such as metastasis have occurred. In addition, we will study the biochemical pathways in human cells by which Arresten is produced in the hopes of learning how production of such factors can be enhanced in the fight against cancer.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Teodoro, Jose G
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $377,699~ $0~